Francisco Ujueta

ORCID: 0000-0002-5346-7996
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peripheral Artery Disease Management
  • Heavy Metal Exposure and Toxicity
  • Trace Elements in Health
  • Cerebrovascular and Carotid Artery Diseases
  • Vascular Procedures and Complications
  • Diabetic Foot Ulcer Assessment and Management
  • Climate Change and Health Impacts
  • Air Quality and Health Impacts
  • Cardiovascular Function and Risk Factors
  • Cardiac electrophysiology and arrhythmias
  • Central Venous Catheters and Hemodialysis
  • Heavy metals in environment
  • Effects and risks of endocrine disrupting chemicals
  • Cardiac Arrhythmias and Treatments
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Muscle and Compartmental Disorders
  • Cardiovascular Disease and Adiposity
  • Infective Endocarditis Diagnosis and Management
  • Renal and Vascular Pathologies
  • Acute Myocardial Infarction Research
  • Anatomy and Medical Technology
  • Vascular anomalies and interventions
  • Diagnosis and Treatment of Venous Diseases
  • Acute Ischemic Stroke Management

Brigham and Women's Hospital
2025

Mount Sinai Medical Center
2018-2024

Columbia University
2020-2023

Jackson Memorial Hospital
2023

University of Miami
2023

Mount Sinai Hospital
2022

NYU Langone Health
2017

Exposure to environmental pollutants is linked increased risk of cardiovascular disease. Beyond the extensive evidence for particulate air pollution, accumulating supports that exposure nonessential metals such as lead, cadmium, and arsenic a significant contributor disease worldwide. Humans are exposed through air, water, soil, food industrial public use. Contaminant interfere with critical intracellular reactions functions leading oxidative stress chronic inflammation result in endothelial...

10.1161/jaha.123.029852 article EN cc-by-nc-nd Journal of the American Heart Association 2023-06-12
Gervasio A. Lamas Kevin J. Anstrom Ana Navas‐Acién Robin Boineau Hayley Nemeth and 95 more Zhen Huang Jun Wen Yves Rosenberg Mario Stylianou Teresa L.Z. Jones Bonnie R. Joubert Qilu Yu Regina M. Santella Ana C. Mon Francisco Ujueta Esteban Escolar David M. Nathan Vivian Fonseca Y. Wady Aude Jonathan K. Ehrman T.S.J. Elliott Rakesh Prashad Eldrin F. Lewis Renato D. Lopes Michael E. Farkouh Anne-Marie Elliott Jonathan Newman Daniel B. Mark Philip Bear Donna Prouty Jodi Baxter Jonathan K. Ehrman Heather Golden Vikrant Katoch Raffi K. Krikorian André Paixão Fujiko Anazawa Leybi Ramirez-Kelly Abby Nolen Venus Barney Gerald Natzke Rodica Pop‐Busui Cindy Plunkett Laura Meyer J. Kirk Roberts Scott A. Rollins Tamra Hollis Nampalli Vijay Melinda Washam David Zidar Terence Semenec Lauren Huntington Amanda Klumpp Matthew S. Doughty Jeffrey Baker Joseph P. Allen Rebecca Cortez Bhaskar Purushottam Kirstin Stauffacher Kelly J. Airey Elena Christofides Jordyn Conway David Hoffman Patty Schuler Ronald M Solbrig Loni Chacon Phillip D. Levy Linda Gojcevic R. Eric Collins John Miles McClure Ellen Mook Christopher R. deFilippi Wendy Sheaffer Antoinette Bonaccorso Daniel Donovan Julee Hartwell Andrew P. Garner Dawn Kalbfliesh David H. Hsi Maryanne Ducey Paula Trump Urs A. Leuenberger Katie Loffredo Betty Persico Allan Magaziner Dennis Goodman Michela L. Garabedian J. Coates Jeanne P. Wingo Sheldon H. Gottlieb Michael Schächter Sally Minniefield Olakunle Akinboboye Kazi Masel Ullah Karen Wolske Dennis Friedman Daniel Lorber M. Tsovian Regina Druz Patricia Hodnett

In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior myocardial infarction (MI).

10.1001/jama.2024.11463 article EN JAMA 2024-08-14
Francisco Ujueta Gervasio A. Lamas Kevin J. Anstrom Ana Navas‐Acién Robin Boineau and 95 more Yves Rosenberg Mario Stylianou Teresa L.Z. Jones Bonnie R. Joubert Qilu Yu Jun Wen Hayley Nemeth Zhen Huang Vivian Fonseca David M. Nathan Gabriel I. Uwaifo Ivan A. Arenas Lan Luo Jeffrey Baker Diana Visentin André Paixão John F. Schmedtje Daniel B. Mark Philip Bear Donna Prouty Jodi Baxter Jonathan K. Ehrman Heather Golden Vikrant Katoch Raffi K. Krikorian André Paixão Fujiko Anazawa Leybi Ramirez-Kelly Abby Nolen Venus Barney Gerald Natzke Rodica Pop‐Busui Cindy Plunkett Laura Meyer J. Kirk Roberts Scott A. Rollins Tamra Hollis Nampalli Vijay Melinda Washam David Zidar Terence Semenec Lauren Huntington Amanda Klumpp Matthew S. Doughty Jeffrey Baker Joseph P. Allen Rebecca Cortez Bhaskar Purushottam Kirstin Stauffacher Kelly J. Airey Elena Christofides Jordyn Conway David Hoffman Patty Schuler Ronald M Solbrig Loni Chacon Phillip D. Levy Linda Gojcevic R. Eric Collins John Miles McClure Ellen Mook Christopher R. deFilippi Wendy Sheaffer Antoinette Bonaccorso Daniel Donovan Julee Hartwell Andrew P. Garner Dawn Kalbfliesh David H. Hsi Maryanne Ducey Paula Trump Urs A. Leuenberger Katie Loffredo Betty Persico Allan Magaziner Dennis Goodman Michela L. Garabedian J. Coates Jeanne P. Wingo Sheldon H. Gottlieb Michael Schächter Sally Minniefield Olakunle Akinboboye Kazi Masel Ullah Karen Wolske Dennis Friedman Daniel Lorber M. Tsovian Regina Druz Patricia Hodnett Stephanie Meller Maria B. Bartolome Giselle Cortez Vargas Ian Ergui Francisco Ujueta

Importance In 2013, the Trial to Assess Chelation Therapy (TACT) reported that in 1708 patients with stable coronary disease and prior myocardial infarction (MI), oral multivitamins multiminerals (OMVMs), a factorial design edetate disodium (EDTA) chelation therapy, did not reduce cardiovascular events relative placebo OMVMs, but active EDTA combined OMVMs was superior OMVM/placebo EDTA. Objective To compare OMVM vs terms of efficacy for reducing major adverse diabetes MI. Design, Setting,...

10.1001/jamainternmed.2024.8408 article EN cc-by JAMA Internal Medicine 2025-03-03

Approximately 1 in 7 US adults have diabetes; and over 60% of deaths patients with diabetes cardiac disease as a principal or contributing cause. Both coronary peripheral artery (PAD) identify high-risk cohorts among diabetes. We previously demonstrated improved cardiovascular outcomes edetate disodium-based chelation post-MI diabetes, enrolled the Trial to Assess Chelation Therapy (TACT). In these analyses we further studied effect size severe 2 vascular beds; coronaries, lower extremity...

10.1016/j.jdiacomp.2019.04.005 article EN cc-by-nc-nd Journal of Diabetes and its Complications 2019-04-14

Background In 2015, there were 30.3 million patients with diabetes in the US, including 25.2% of people ages 65 or older and 108,000 hospitalizations for non-traumatic amputations. Severe diabetic limb disease includes critical ischemia (CLI ) due to an infrapopliteal foot pain ischemic ulcerations gangrene. Environmentally acquired toxic metals, such as lead cadmium, have been associated cardiovascular disease. Thus, we designed present unblinded pilot study determine whether was a signal...

10.7759/cureus.6477 article EN Cureus 2019-12-27

Peripheral artery disease (PAD) is a progressive form of atherosclerosis that affects the lower extremities, particularly in patients with diabetes. Critical limb ischemia (CLI), end-stage manifestation this disease, associated an increased risk chronic leg ulcerations, infections, amputations, and mortality. At presentation, 30% CLI require amputation, 25% will die within 1 year (1). Toxic metal exposure, to cadmium, has been vascular epidemiological studies PAD severity coronary (CAD)...

10.2337/cd18-0059 article EN cc-by-nc-nd Clinical Diabetes 2019-01-12

10.1016/s0735-1097(24)06139-4 article EN Journal of the American College of Cardiology 2024-04-01
Coming Soon ...